HM
Therapeutic Areas
Chordia Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| rogocekib (CTX-712) | Oncology (unspecified) | Phase 1/2 |
| CTX-177 (ONO-7018) | Immunology/Oncology | Phase 1 |
| CTX-439 | Oncology | Preclinical/Research |
| CRD-1968099 | Oncology/Immunology | Preclinical |